Connect with us

Health

Targeted drug shows promising activity in kidney cancer patients with brain metastases – News-Medical.Net

A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response…

Published

on

Article feature image

A targeted drug has shown promising activity against brain metastases resulting from kidney cancer, achieving a 50 percent response rate, and supporting further studies of the drug in this patient group whose poor prognosis has created a significant unmet…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending